How to Get Finasteride in North Dakota

What Is Finasteride and Why Do Patients in North Dakota Seek It?

Finasteride is a 5-alpha reductase type II inhibitor that blocks conversion of testosterone to dihydrotestosterone (DHT), the androgen primarily responsible for androgenetic alopecia (AGA) and benign prostatic hyperplasia (BPH). For AGA, the FDA-approved dose is 1 mg orally once daily; for BPH, 5 mg orally once daily. Both doses are available as low-cost generics from multiple manufacturers since Merck's Proscar and Propecia patents expired.

In North Dakota, an estimated 330,000 men are age 30 or older, the demographic most affected by AGA. DHT miniaturizes hair follicles in a genetically predisposed pattern, and finasteride interrupts that process at the enzymatic level. The key two-year randomized controlled trial by Kaufman et al. (N=1,553) published in the Journal of the American Academy of Dermatology demonstrated a 48% increase in hair count from baseline with 1 mg finasteride versus a 9.9% decrease with placebo [1]. A separate one-year analysis in the same cohort confirmed statistically significant improvement in both standardized photographic assessment and patient self-rating [1].

The compound also carries an FDA-approved indication for BPH at 5 mg daily, where the PLESS trial (N=3,040 to 4 years) showed a 57% reduction in the risk of acute urinary retention and a 55% reduction in BPH-related surgery compared with placebo [2].

Because finasteride requires a prescription under federal and North Dakota law, obtaining it means engaging a licensed prescriber, which today includes telehealth options that did not exist a decade ago.

North Dakota Prescribing Law and Telehealth Authority

North Dakota permits licensed prescribers to issue prescriptions via synchronous and asynchronous telehealth under North Dakota Century Code chapter 43-17 and the North Dakota Board of Medicine's telehealth policy. A valid prescriber-patient relationship must be established before a controlled substance or prescription drug is issued, but finasteride is not a controlled substance, so the documentation threshold is lower than for Schedule III-V drugs.

Prescribers must hold an active North Dakota license or qualify under an interstate compact arrangement recognized by the state. The Interstate Medical Licensure Compact (IMLC) currently includes North Dakota as a member state, meaning physicians licensed through the compact may treat and prescribe to North Dakota patients [3]. Nurse practitioners operating under the Nurse Licensure Compact (NLC) have similar multi-state authority [4].

The North Dakota Board of Pharmacy regulates prescription dispensing. Any out-of-state pharmacy shipping finasteride to a North Dakota address must hold a valid non-resident pharmacy permit issued by the board. Patients should verify permit status at the board's public license lookup before purchasing from an online pharmacy.

The FDA's guidance on internet pharmacy red flags notes that any site offering prescription drugs without a valid prescription is operating illegally [5]. A licensed telehealth visit is the legally sound path to obtaining finasteride online.

How to Get a Finasteride Prescription in North Dakota: Step by Step

Getting a finasteride prescription in North Dakota follows four steps regardless of whether the visit is in-person or via telehealth.

Step 1. Choose a prescriber pathway. Options include a primary care physician (PCP), a dermatologist, a urologist (more common for BPH), or a licensed telehealth platform serving North Dakota. PCPs and dermatologists in Fargo, Bismarck, Grand Forks, and Minot routinely prescribe finasteride. Telehealth platforms such as Hims, Roman, Keeps, and HealthRX offer North Dakota-specific prescribing through licensed providers.

Step 2. Complete the clinical intake. The prescriber reviews your hair loss history, photographs or a live video assessment, current medications, and personal or family history of prostate cancer. For BPH, a urological symptom score (AUA-SI) and digital rectal exam history factor into the decision. The FDA label for finasteride 5 mg explicitly states that a baseline PSA measurement should be obtained before initiating therapy, because finasteride suppresses PSA by approximately 50% and a rising PSA on therapy warrants investigation [6].

Step 3. Receive the prescription. The prescriber sends an electronic prescription (e-Rx) to your chosen pharmacy. North Dakota pharmacies accept e-Rx under state law. The prescription may be written for up to a 90-day supply with up to five refills (finasteride is not a controlled substance, so refill limits are at prescriber discretion).

Step 4. Fill and ship. Retail pharmacies in Fargo (including Sanford and CHI pharmacy networks), Bismarck, and most rural North Dakota towns stock generic finasteride. GoodRx and similar discount programs bring the cash price for a 30-day supply of 1 mg generic finasteride to roughly $14, $22 at Walmart, Costco, and Walgreens locations across the state [7].

Telehealth Providers Prescribing Finasteride in North Dakota

Several telehealth platforms are licensed to serve North Dakota patients and have prescribers with active North Dakota authority or IMLC licensure. The visit is typically asynchronous (photo + questionnaire) for straightforward AGA in men under 50 with no complicating history. Synchronous video visits are more common when BPH is the indication or when the patient reports prior prostate cancer screening results that need clinical interpretation.

During a standard telehealth intake for AGA, the clinician typically asks about:

• Duration and pattern of hair loss (Norwood-Hamilton scale)
• Family history of AGA on maternal and paternal sides
• Current medications, especially anticoagulants or other 5-alpha reductase inhibitors
• History of liver disease (finasteride is hepatically metabolized via CYP3A4)
• Sexual health baseline, because the FDA label notes post-marketing reports of persistent sexual side effects in a subset of users [6]

After the visit, the e-Rx is sent to a pharmacy of your choice or to the platform's affiliated pharmacy. Turnaround from intake completion to prescription in-hand is typically 24 to 48 hours for asynchronous platforms and same-day for synchronous video visits.

The HealthRX North Dakota Finasteride Access Framework categorizes patients into three prescriber pathways based on clinical complexity:

• Tier 1 (standard AGA, age 18, 49, no PSA concern): Asynchronous telehealth visit, e-Rx to retail or mail pharmacy, no mandatory labs.
• Tier 2 (AGA age 50+, or BPH symptoms, or elevated PSA history): Synchronous telehealth or in-person visit, baseline PSA required, consider urology co-management.
• Tier 3 (BPH with retention history, prior prostate biopsy, or concurrent alpha-blocker use): In-person urology referral preferred before or concurrent with finasteride initiation.

This tiered framework is not a published clinical guideline but reflects the standard-of-care logic documented in the 2021 American Urological Association BPH guidelines and the 2017 American Academy of Dermatology AGA guidelines [8][9].

Labs Required Before Starting Finasteride in North Dakota

Lab requirements vary by indication and patient age. For otherwise healthy men under 50 seeking 1 mg finasteride for AGA, no blood tests are mandated by FDA labeling or ADA guidelines. The clinician may still request labs at their discretion.

For men 50 and older, or any man with a personal or family history of prostate cancer, the FDA label for finasteride 5 mg (Proscar) states: "Prior to initiating therapy with finasteride for BPH, consideration should be given to other urological conditions... A baseline PSA measurement should be established." [6] The PCPT trial (N=18,882) showed that finasteride reduced prostate cancer detection by 24.8% overall but increased detection of high-grade tumors in the finasteride arm (6.4% vs. 5.1%), a finding that reinforced the need for PSA monitoring during therapy [10]. The AUA and American Cancer Society recommend that men on finasteride have their PSA values interpreted using the adjustment factor of doubling the observed PSA to estimate the true underlying level [9].

Standard labs that North Dakota telehealth providers commonly order before finasteride:

• PSA (prostate-specific antigen): Baseline for men 45+ or with BPH symptoms
• Liver function tests (LFTs): Ordered selectively if the patient has hepatic risk factors
• Testosterone and DHT levels: Not routinely required for AGA but may be drawn in patients with broader hormonal concerns

LabCorp and Quest Diagnostics both operate patient service centers in Fargo, Bismarck, Grand Forks, and Minot, with most telehealth platforms able to send lab orders electronically to either network. Results are typically available within 24 to 48 hours of the draw [11].

503A Compounding Pharmacies and Finasteride in North Dakota

A 503A pharmacy compounds drug preparations for individual patients under a valid prescription. North Dakota-licensed 503A compounders may prepare finasteride in non-standard doses or alternative delivery vehicles (for example, topical finasteride solutions) that are not available as FDA-approved commercial products.

Topical finasteride has attracted research interest because systemic DHT suppression may be lower than with oral administration, potentially reducing the frequency of systemic side effects. A 2018 randomized study (N=323) published in the Journal of the American Academy of Dermatology found that topical finasteride 0.25% once daily produced hair count results comparable to oral finasteride 1 mg, with significantly lower serum DHT suppression (30.5% vs. 71.4%, P<0.001) [12]. North Dakota 503A pharmacies may compound topical finasteride under a physician's prescription, though the FDA has not approved any topical finasteride product and compounded versions are not substitutable for an FDA-approved drug.

When choosing a 503A pharmacy, confirm the following:

• Active North Dakota Board of Pharmacy permit (resident or non-resident)
• USP 795/797 compliance certification for the relevant dosage form
• Valid prescription on file before compounding begins

The FDA's guidance on 503A compounding distinguishes these pharmacies from 503B outsourcing facilities, which may produce larger batches without patient-specific prescriptions [5]. For finasteride, individual 503A compounding is the relevant category in North Dakota.

Filling Your Finasteride Prescription at North Dakota Pharmacies

Every major pharmacy chain operating in North Dakota stocks generic finasteride. The table below reflects typical cash pricing verified through publicly available discount-card databases as of early 2025.

| Pharmacy | 30-day supply (1 mg generic) | 90-day supply | |---|---|---| | Walmart (ND locations) | ~$14 | ~$30 | | Walgreens | ~$22 | ~$55 | | Costco Pharmacy | ~$14 | ~$28 | | Hy-Vee Pharmacy | ~$18 | ~$48 | | Independent ND pharmacy (GoodRx) | ~$15, $28 | ~$38, $70 |

Mail-order pharmacy programs through Express Scripts and CVS Caremark (both contracted with major North Dakota employer health plans) typically provide 90-day supplies with reduced copays for insured patients. North Dakota Medicaid does not cover finasteride for AGA; BPH coverage requires prior authorization and documentation of symptom severity scores and failure of alpha-blocker monotherapy.

North Dakota Medicaid, Insurance, and Prior Authorization

Commercial insurance coverage for finasteride in North Dakota varies by plan. Finasteride 5 mg for BPH is on most commercial formularies as a Tier 1 or Tier 2 generic, which means copays of $5, $20 per 30-day supply are common. Finasteride 1 mg for AGA is frequently classified as cosmetic by insurers and excluded from coverage, consistent with the National Committee for Quality Assurance (NCQA) guideline that excludes drugs prescribed solely for cosmetic purposes from mandatory coverage [13].

Prior authorization for BPH finasteride through North Dakota Medicaid typically requires:

• AUA Symptom Index (AUA-SI) score of 8 or higher (moderate symptoms)
• Documentation of at least one alpha-blocker trial (e.g., tamsulosin 0.4 mg for 4 to 8 weeks)
• Current PSA value and digital rectal exam findings within the past 12 months
• Prescriber attestation that the diagnosis is BPH, not prostate cancer

The prior authorization process typically takes 3, 5 business days. If denied, a peer-to-peer review between the prescribing physician and the plan's medical director is the standard first-level appeal [14].

Transferring a Finasteride Prescription to North Dakota

Patients relocating to North Dakota who already have an active finasteride prescription in another state may transfer it. Under federal law (21 CFR 1306.25), non-controlled substance prescriptions may be transferred between pharmacies. The receiving North Dakota pharmacy contacts the dispensing pharmacy directly. If the original prescription has remaining refills, those transfer with it.

Telehealth prescriptions issued by an out-of-state provider who does not hold North Dakota licensure or IMLC membership are not valid in North Dakota, even if the patient has relocated. The patient must establish a new prescriber relationship with a North Dakota-licensed provider before new prescriptions can be written. Most telehealth platforms support this automatically when a patient updates their state of residence in the platform's patient portal.

What to Expect: Timeline and Efficacy Data

Finasteride does not produce instant results. Understanding the clinical timeline prevents premature discontinuation, which is the most common reason patients fail to see the drug's full benefit.

• Weeks 1, 12: DHT suppression begins within 24 hours of the first dose. Serum DHT falls approximately 60 to 70% with 1 mg daily and 70 to 75% with 5 mg daily within two weeks [6]. Hair loss shedding may temporarily worsen in weeks 4, 8 as follicles transition from telogen to anagen phase.
• Month 3, 6: Slowing of hair loss progression is the first measurable clinical endpoint. Standardized global photography at 12 weeks shows stabilization in the majority of responders.
• Month 6, 12: New hair growth becomes visible. The Kaufman et al. two-year trial showed that patients who responded at 12 months continued to improve through 24 months [1].
• Year 2 and beyond: The 5-year open-label extension of the original finasteride AGA trials (N=279) showed that 77% of men maintained or increased their hair count relative to baseline at 5 years, compared with a 100% rate of progressive loss in the placebo group [15].

Discontinuation results in reversal of benefit. Within 12 months of stopping finasteride, most patients return to the hair loss trajectory they would have followed without treatment [1].

Side Effects, Sexual Health, and Post-Finasteride Syndrome

The FDA label lists sexual adverse effects, including decreased libido, erectile dysfunction, and decreased ejaculate volume, occurring in 1.8 to 3.8% of men in clinical trials at 1 mg dosing [6]. These rates were similar to placebo in the original trials; the placebo group reported sexual dysfunction in 1.3 to 2.2% of subjects. Post-marketing surveillance has generated reports of persistent sexual, neurological, and psychological symptoms following discontinuation, a constellation sometimes called Post-Finasteride Syndrome (PFS). The FDA added a label update in 2012 noting that these persistent effects had been reported, though a causal mechanism has not been established in peer-reviewed literature [6][16].

Patients should discuss sexual health baseline and any pre-existing mood disorders with their prescriber before starting finasteride. The 2023 systematic review by Dyson et al. in JAMA Dermatology (N=14 studies, 19,934 patients) found that the absolute risk of persistent sexual dysfunction attributable to finasteride remains statistically uncertain due to heterogeneous study designs and lack of long-term placebo-controlled follow-up [16].

Finasteride is teratogenic to male fetuses. Pregnant women or women who may become pregnant must not handle crushed or broken finasteride tablets. This FDA Pregnancy Category X designation applies to both the 1 mg and 5 mg formulations [6].

Combining Finasteride with Other Hair Loss Treatments

Finasteride is frequently combined with minoxidil, the only other FDA-approved treatment for AGA. Minoxidil acts through a different mechanism (vasodilation and potassium channel opening at the follicle level), and the two drugs are additive rather than redundant. A randomized trial by Hu et al. (N=450 to 12 months) showed that the combination of oral minoxidil 0.25 mg and oral finasteride 1 mg produced greater increases in hair count than either agent alone (P<0.01) [17].

Low-level laser therapy (LLLT) devices cleared by the FDA as 510(k) medical devices (e.g., iGrow, HairMax LaserComb) are sometimes added to finasteride regimens. The evidence base for LLLT is weaker than for finasteride or minoxidil, but a 2014 randomized trial (N=44) showed statistically significant improvement in hair density at 26 weeks versus sham device [18]. North Dakota dermatologists and telehealth providers may recommend combination approaches based on Norwood scale staging and patient preference.